These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1819729

  • 21. Role for platelet-activating factor in asthma.
    Chung KF, Barnes PJ.
    Lipids; 1991 Dec; 26(12):1277-9. PubMed ID: 1819715
    [Abstract] [Full Text] [Related]

  • 22. Developmental susceptibility to intestinal injury by platelet-activating factor in the newborn rat.
    Bhatia AM, Ramos CT, Scott SM, Musemeche CA.
    J Invest Surg; 1996 Dec; 9(5):351-8. PubMed ID: 8951658
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Platelet-activating factor in infants at risk for necrotizing enterocolitis.
    Rabinowitz SS, Dzakpasu P, Piecuch S, Leblanc P, Valencia G, Kornecki E.
    J Pediatr; 2001 Jan; 138(1):81-6. PubMed ID: 11148517
    [Abstract] [Full Text] [Related]

  • 28. [Phospholipid thrombocyte activating factor, its analogs and antagonists: prospects of their use in medicine].
    Kulikov VI, Muzia GI.
    Vestn Akad Med Nauk SSSR; 1991 Jan; (10):13-7. PubMed ID: 1801455
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Treatment of carrageenan induced arthritis by the platelet activating factor antagonist BN 50730.
    Hilliquin P, Natour J, Aissa J, Guinot P, Laoussadi S, Benveniste J, Menkes CJ, Arnoux B.
    Ann Rheum Dis; 1995 Feb; 54(2):140-3. PubMed ID: 7702404
    [Abstract] [Full Text] [Related]

  • 31. Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality.
    Libert C, Van Molle W, Brouckaert P, Fiers W.
    J Inflamm; 1995 Feb; 46(3):139-43. PubMed ID: 8844494
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Platelet-activating factor mediates pulmonary macromolecular leak following intestinal ischemia-reperfusion.
    Carter MB, Wilson MA, Wead WB, Garrison RN.
    J Surg Res; 1996 Feb 01; 60(2):403-8. PubMed ID: 8598677
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Involvement of platelet-activating factor (PAF) in septic shock and priming as indicated by the effect of hetrazepinoic PAF antagonists.
    Heuer HO.
    Lipids; 1991 Dec 01; 26(12):1369-73. PubMed ID: 1819735
    [Abstract] [Full Text] [Related]

  • 38. [Effects of the PAF antagonist WEB 2086 on hypoxia and angiotensin II-induced pulmonary vasoconstriction in the isolated perfused rat lung].
    Kempfert C, Brandt R, Siewert B, Kanowski U, Oddoy A.
    Pneumologie; 1991 Oct 01; 45(10):799-803. PubMed ID: 1758848
    [Abstract] [Full Text] [Related]

  • 39. Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis.
    Caplan MS, Sun XM, Hseuh W, Hageman JR.
    J Pediatr; 1990 Jun 01; 116(6):960-4. PubMed ID: 2348301
    [Abstract] [Full Text] [Related]

  • 40. Experimental model of ischemic bowel necrosis. The role of platelet-activating factor and endotoxin.
    Gonzalez-Crussi F, Hsueh W.
    Am J Pathol; 1983 Jul 01; 112(1):127-35. PubMed ID: 6859226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.